Literature DB >> 16206259

Study on the drug release property of cholesteryl end-functionalized poly(epsilon-caprolactone) microspheres.

Lan Yu1, Hua Zhang, Si-Xue Cheng, Ren-Xi Zhuo, Hua Li.   

Abstract

End-functionalized poly/oligo(epsilon-caprolactone)s were synthesized through the ring-opening polymerization of epsilon-caprolactone initiated by cholesterol with a hydroxyl group. Using the end-functionalized poly/oligo(epsilon-caprolactone)s with different molecular weights, the microsphere drug delivery systems were fabricated using a convenient melting-emulsion method. The drug release properties of microspheres were investigated with the presence of an enzyme, Pseudomonas cepacia lipase, as well as in the absence of the enzyme. The release profiles can be fitted nicely by the classical empirical exponential expression. Under the hydrolytic condition, the drug release is mainly controlled by Fickian diffusion, and the high molecular weight of the matrix results in a slower drug release rate. Under the enzymatic condition, the drug release is dominated by combined degradation and diffusion mechanism, and the high molecular weight sample exhibits a faster release rate that is mainly caused by the higher degradation rate of the sample with lower cholesteryl moiety content.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16206259     DOI: 10.1002/jbm.b.30395

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  2 in total

1.  Self-assembled micellar aggregates based monomethoxyl poly(ethylene glycol)-b-poly(ε-caprolactone)-b-poly(aminoethyl methacrylate) triblock copolymers as efficient gene delivery vectors.

Authors:  Ming Ma; Feng Li; Xiu-hong Liu; Zhe-fan Yuan; Fu-jie Chen; Ren-xi Zhuo
Journal:  J Mater Sci Mater Med       Date:  2010-09-21       Impact factor: 3.896

2.  Formulation and in vitro characterization of rifampicin-loaded porous poly (ε-caprolactone) microspheres for sustained skeletal delivery.

Authors:  Quanjing Mei; Peipei Luo; Yi Zuo; Jidong Li; Qin Zou; Yubao Li; Dianming Jiang; Yaning Wang
Journal:  Drug Des Devel Ther       Date:  2018-05-31       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.